|
|
Volumn 7, Issue 3, 2001, Pages 262-
|
|
Experts predict bleak post-genomic era for drug R&D
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG;
BUDGET;
COST BENEFIT ANALYSIS;
DRUG RESEARCH;
DRUG TARGETING;
FINANCE;
GENE SEQUENCE;
HUMAN;
INVESTMENT;
MEDICAL GENETICS;
MONEY;
NOTE;
PHENOTYPE;
PRIORITY JOURNAL;
SINGLE NUCLEOTIDE POLYMORPHISM;
VALIDATION PROCESS;
ALBURNUS ALBURNUS;
|
|
EID: 0035099435
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/85364 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|